A Little Help From Our Friends
FDA approval of Zimulti/Acomplia/rimonabant is running at about the same pace as the attorney for my sister’s estate. (Oops! I didn’t say that, did I?)
Zimulti will be the name in the U.S. for this drug that helps people lose weight, reduce their waistlines, lower the amount of fat in the blood and increase HDL–the “good” cholesterol. It also has been shown to reduce the nasty hold that nicotine has on smokers, although it has not been licensed for this purpose.
On June 13, an ad hoc panel of medical pros selected by the FDA will deliver its opinion on the safety and efficacy of Zimulti. The agency is slated (again) to publish its final opinion in July.
Many speculate that the fen-phen diet pill scare a few years back has made the FDA gun-shy about all diet drugs. However, it is anticipated that the FDA will ultimately approve Zimulti, as have most EU countries and the UK.
I’m pleased to say I don’t meet the recommended body mass index of 30 or higher that might inspire my physician to prescribe Zimulti. But I’m not above begging or bribery!
